Effects of okadaic acid on the GABA_A current rundown. by Mounia SidAhmed-Mezi (589159)

“…(D Left) Rundown profiles of normalized currents in presence (n = 17) or in absence (Control, n = 11) of okadaic acid; (D Right) color-coded hierarchical clustering tree for the recorded okadaic acid-treated cells in which a maximum of 4 groups are significantly distinguished: ‘Very Slow’ (n = 3), ‘Mid Slow’ (n = 5), ‘Mid Rapid’ (n = 4) and ‘Very Rapid’ (n = 5). …”

The biological function of LINC00857 in PAAD was discovered. by Tingfu Li (5472584)

Molecular Imaging of Ischemia and Reperfusion in Vivo with Mitochondrial Autofluorescence by Hsueh-Han Lu (1802653)

“…The autofluorescence decayed rapidly from the baseline immediately after 20-min ischemia (approximately 30% decrease in 5 min) but recovered gradually during reperfusion (to approximately 99% of the baseline 9 min after the onset of reperfusion). …”

Molecular Imaging of Ischemia and Reperfusion in Vivo with Mitochondrial Autofluorescence by Hsueh-Han Lu (1802653)

“…The autofluorescence decayed rapidly from the baseline immediately after 20-min ischemia (approximately 30% decrease in 5 min) but recovered gradually during reperfusion (to approximately 99% of the baseline 9 min after the onset of reperfusion). …”

LDH-A is required for PMVECs to sustain aerobic glycolysis and rapid growth. by Glenda Parra-Bonilla (463564)

“…<p>Western blot analysis demonstrates that LDH-A protein decreases in the absence of doxycycline over a 7-day time course (A) resulting in decreased lactate production (B), glucose consumption (C) and PMVEC growth (D). …”

Dynamics of CMV-specific CD8⁺ T-cells and CD8⁺ T_EM/EMRA cells in CMV+ and CMV- individuals. by Sara P. H. van den Berg (8703927)

DataSheet_1_Early changes of bone metabolites and lymphocyte subsets may participate in osteoporosis onset: a preliminary study of a postmenopausal osteoporosis mouse model.pdf by Sizhu Wang (18067321)

Mechanistic Investigation of the Hydrogenation of Ketones Catalyzed by a Ruthenium(II) Complex Featuring an N-Heterocyclic Carbene with a Tethered Primary Amine Donor: Evidence for... by Wylie W. N. O (1755865)

“…On the other hand, the energy barriers for an inner-sphere mechanism involving the decoordination of the amine group of the NHC ligand, the heterolytic splitting of dihydrogen across a Ru−O(alkoxide) bond, and hydride migration to the coordinated ketone, are respectively 15.5, 17.5, and 15.6 kcal/mol uphill at 298 K and 1 atm. …”

Mechanistic Investigation of the Hydrogenation of Ketones Catalyzed by a Ruthenium(II) Complex Featuring an N-Heterocyclic Carbene with a Tethered Primary Amine Donor: Evidence for... by Wylie W. N. O (1755865)

“…On the other hand, the energy barriers for an inner-sphere mechanism involving the decoordination of the amine group of the NHC ligand, the heterolytic splitting of dihydrogen across a Ru−O(alkoxide) bond, and hydride migration to the coordinated ketone, are respectively 15.5, 17.5, and 15.6 kcal/mol uphill at 298 K and 1 atm. …”

Mechanistic Investigation of the Hydrogenation of Ketones Catalyzed by a Ruthenium(II) Complex Featuring an N-Heterocyclic Carbene with a Tethered Primary Amine Donor: Evidence for... by Wylie W. N. O (1755865)

“…On the other hand, the energy barriers for an inner-sphere mechanism involving the decoordination of the amine group of the NHC ligand, the heterolytic splitting of dihydrogen across a Ru−O(alkoxide) bond, and hydride migration to the coordinated ketone, are respectively 15.5, 17.5, and 15.6 kcal/mol uphill at 298 K and 1 atm. …”

<i>OsNF-YAs</i> RNAi mutants are more resistant to viruses. by Xiaoxiang Tan (12542842)

Pharmacologiic Inhibition of protein kinase A improved antioxidant activities in endothelial cells. by Zhaoyun Zhang (118032)

“…C: Catalase activity increase. D: ROS level decrease. E: TBARs level decrease. *, p<0.05 compared with 25 mM condition. #, p<0.05 compared with 5.6 mM condition. n = 8.…”

Ku0063794 and temsirolimus inhibited tumor growth in a xenograft model of RCC. by Hao Zhang (15339)

“…<p>(<b>A</b>) The treatment with Ku0063794 or temsirolimus significantly inhibited tumor growth in Nu/Nu nude mice. …”

Collecting data from a woodlot of York University (Keele campus) by Melinaz_ Barati (3118581)

“…Vertebrates and invertebrates were observed, using a naked eye. For invertebrates, the length of the transect was shortened to a 5 meter radius. …”

OsNF-YAs negatively modulate rice resistance to RSV and SRBSDV. by Xiaoxiang Tan (12542842)

Raw data. by Dominic Michael Rasp (19959412)

“…Our new instruction and variables (Fz_VH, Fres_VH, M_F_ortho_VH) showed better validity (mean r = 0.77, r = 0.81, and r = 0.85) and equally good or better reliability (ICCs: 0.87, 0.89, and 0.94; CVs: 4.7%, 4.1%, and 4.7%) than the original instruction and variable (Fz_V) (mean r = 0.70; ICC: 0.91; CV: 5.6%). There were no differences in muscle activities between the variables and instructions of the 90:20 IPCT. …”

Table_1_Dysregulation of Principal Circulating miRNAs in Non-human Primates Following Ischemic Stroke.XLSX by Jian Chen (15340)

“…For example, mml-miR-191-5p, miR-421, miR-409-5p, and let-7g-5p were found to be significantly overexpressed, whereas mml-miR-128a-5p_R − 2, miR-431_R − 1, and let-7g-3p_1ss22CT were significantly downregulated. …”

A20 protects GSCs from TNFα-induced apoptosis. by Anita B. Hjelmeland (104655)

“…<p>(A and B) The percentage of Annexin V–positive cells increases with TNFα treatment of non-stem glioma cells, but not matched GSC-enriched cultures, isolated from a D456MG (A) or a T3359 (B) patient specimen passaged short term in immunocompromised mice. …”

A Spectroscopic Study of OB Stars Located in the Outer Galactic Disk by Gustavo Bragança (98330)

“…We have obtained high-resolution, echelle spectra for a sample of 137 OB stars located towards the Galactic anticenter using the 6.5m Magellan Clay telescope + MIKE spectrograph. …”

CyberKnife radiation therapy as a platform for translational mouse studies by Martha Kiljan (10885523)

“…<p>Radiation therapy (RT) is a common nonsurgical treatment in the management of patients with cancer. …”